Result of FASTA (omim) for
pF1KB5880
FASTA searches a protein or DNA sequence data bank 36.3.4 Apr, 2011
Please cite:
W.R. Pearson & D.J. Lipman PNAS (1988) 85:2444-2448
Query: pF1KB5880, 496 aa
1>>>pF1KB5880 496 - 496 aa - 496 aa
Library: /omim/omim.rfq.tfa
60827320 residues in 85289 sequences
Statistics: Expectation_n fit: rho(ln(x))= 6.7439+/-0.000352; mu= 11.5701+/- 0.022
mean_var=110.2375+/-21.702, 0's: 0 Z-trim(117.4): 13 B-trim: 343 in 1/53
Lambda= 0.122155
statistics sampled from 29300 (29313) to 29300 sequences
Algorithm: FASTA (3.7 Nov 2010) [optimized]
Parameters: BL50 matrix (15:-5), open/ext: -10/-2
ktup: 2, E-join: 1 (0.697), E-opt: 0.2 (0.344), width: 16
Scan time: 7.310
The best scores are: opt bits E(85289)
NP_066565 (OMIM: 160993) glycylpeptide N-tetradeca ( 496) 3374 605.5 1.1e-172
XP_011523160 (OMIM: 160993) PREDICTED: glycylpepti ( 515) 3018 542.7 9e-154
NP_004799 (OMIM: 603801) glycylpeptide N-tetradeca ( 498) 2454 443.3 7.3e-124
XP_005252699 (OMIM: 603801) PREDICTED: glycylpepti ( 495) 2419 437.2 5.2e-122
XP_016872436 (OMIM: 603801) PREDICTED: glycylpepti ( 502) 2419 437.2 5.3e-122
NP_001295224 (OMIM: 603801) glycylpeptide N-tetrad ( 485) 2373 429.1 1.4e-119
XP_016872442 (OMIM: 603801) PREDICTED: glycylpepti ( 411) 2355 425.8 1.1e-118
XP_016872438 (OMIM: 603801) PREDICTED: glycylpepti ( 482) 2338 422.9 1e-117
XP_016872437 (OMIM: 603801) PREDICTED: glycylpepti ( 489) 2338 422.9 1e-117
XP_016872441 (OMIM: 603801) PREDICTED: glycylpepti ( 415) 2320 419.7 8.1e-117
XP_016872440 (OMIM: 603801) PREDICTED: glycylpepti ( 428) 1150 213.5 9.8e-55
XP_006717602 (OMIM: 603801) PREDICTED: glycylpepti ( 441) 1150 213.5 1e-54
XP_016872439 (OMIM: 603801) PREDICTED: glycylpepti ( 445) 1115 207.3 7.2e-53
>>NP_066565 (OMIM: 160993) glycylpeptide N-tetradecanoyl (496 aa)
initn: 3374 init1: 3374 opt: 3374 Z-score: 3221.0 bits: 605.5 E(85289): 1.1e-172
Smith-Waterman score: 3374; 100.0% identity (100.0% similar) in 496 aa overlap (1-496:1-496)
10 20 30 40 50 60
pF1KB5 MADESETAVKPPAPPLPQMMEGNGNGHEHCSDCENEEDNSYNRGGLSPANDTGAKKKKKK
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_066 MADESETAVKPPAPPLPQMMEGNGNGHEHCSDCENEEDNSYNRGGLSPANDTGAKKKKKK
10 20 30 40 50 60
70 80 90 100 110 120
pF1KB5 QKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQGPAKTMEEASKRSYQFW
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_066 QKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQGPAKTMEEASKRSYQFW
70 80 90 100 110 120
130 140 150 160 170 180
pF1KB5 DTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_066 DTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENY
130 140 150 160 170 180
190 200 210 220 230 240
pF1KB5 VEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEK
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_066 VEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEK
190 200 210 220 230 240
250 260 270 280 290 300
pF1KB5 KMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_066 KMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRS
250 260 270 280 290 300
310 320 330 340 350 360
pF1KB5 LNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQF
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_066 LNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQF
310 320 330 340 350 360
370 380 390 400 410 420
pF1KB5 HLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_066 HLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAY
370 380 390 400 410 420
430 440 450 460 470 480
pF1KB5 SFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
NP_066 SFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN
430 440 450 460 470 480
490
pF1KB5 WKCPSMGAEKVGLVLQ
::::::::::::::::
NP_066 WKCPSMGAEKVGLVLQ
490
>>XP_011523160 (OMIM: 160993) PREDICTED: glycylpeptide N (515 aa)
initn: 3018 init1: 3018 opt: 3018 Z-score: 2881.6 bits: 542.7 E(85289): 9e-154
Smith-Waterman score: 3018; 100.0% identity (100.0% similar) in 444 aa overlap (1-444:1-444)
10 20 30 40 50 60
pF1KB5 MADESETAVKPPAPPLPQMMEGNGNGHEHCSDCENEEDNSYNRGGLSPANDTGAKKKKKK
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 MADESETAVKPPAPPLPQMMEGNGNGHEHCSDCENEEDNSYNRGGLSPANDTGAKKKKKK
10 20 30 40 50 60
70 80 90 100 110 120
pF1KB5 QKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQGPAKTMEEASKRSYQFW
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 QKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQGPAKTMEEASKRSYQFW
70 80 90 100 110 120
130 140 150 160 170 180
pF1KB5 DTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 DTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENY
130 140 150 160 170 180
190 200 210 220 230 240
pF1KB5 VEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEK
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 VEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEK
190 200 210 220 230 240
250 260 270 280 290 300
pF1KB5 KMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRS
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 KMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRS
250 260 270 280 290 300
310 320 330 340 350 360
pF1KB5 LNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQF
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 LNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQF
310 320 330 340 350 360
370 380 390 400 410 420
pF1KB5 HLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAY
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
XP_011 HLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAY
370 380 390 400 410 420
430 440 450 460 470 480
pF1KB5 SFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYN
::::::::::::::::::::::::
XP_011 SFYNVHTQTPLLDLMSDALVLAKMVRSRRGGLWRCAGKRQWSHGEHSSRDAASHGLEALS
430 440 450 460 470 480
>>NP_004799 (OMIM: 603801) glycylpeptide N-tetradecanoyl (498 aa)
initn: 2573 init1: 2387 opt: 2454 Z-score: 2344.7 bits: 443.3 E(85289): 7.3e-124
Smith-Waterman score: 2519; 73.2% identity (88.6% similar) in 508 aa overlap (1-496:1-498)
10 20 30 40 50
pF1KB5 MADESETAVKPPAPPLPQMMEGNGNGHEHCS-DCENEEDNSYNRGGLSPANDTGAKKKKK
::..::.:.. . : . .. :. : .:::.. . .: ::.. :::::::
NP_004 MAEDSESAASQQSLEL--------DDQDTCGIDGDNEEETEHAKG--SPGGYLGAKKKKK
10 20 30 40 50
60 70 80 90 100
pF1KB5 KQKKKKEK----GSETDSAQD-------QPVKMNSLPAERIQEIQKAIELFSVGQGPAKT
:::.:::: :...:::.: :: : :.: ...:.::.:.::.:. ::::..
NP_004 KQKRKKEKPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARN
60 70 80 90 100 110
110 120 130 140 150 160
pF1KB5 MEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGV
..::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.: :
NP_004 IDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEV
120 130 140 150 160 170
170 180 190 200 210 220
pF1KB5 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISA
::::::::::::::::::::::::::::::::::::::: :::::::: :..::::::::
NP_004 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISA
180 190 200 210 220 230
230 240 250 260 270 280
pF1KB5 IPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLP
:::::.:::. ::::::::::::::::::::::::::::::::.::::::::::::::::
NP_004 IPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLP
240 250 260 270 280 290
290 300 310 320 330 340
pF1KB5 KPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPV
::..::::::::::::::.::::::::::::.::::::::::.. ::.:::::: :::
NP_004 KPIATCRYWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKS
300 310 320 330 340 350
350 360 370 380 390 400
pF1KB5 VHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIM
:..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::::.:
NP_004 VRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVM
360 370 380 390 400 410
410 420 430 440 450 460
pF1KB5 NHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFG
.::.::::::::::::.::.:::::::::::.::: ::::::::::::::::::::::::
NP_004 HHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFG
420 430 440 450 460 470
470 480 490
pF1KB5 IGDGNLQYYLYNWKCPSMGAEKVGLVLQ
:::::::::::::.::. .::::::::
NP_004 IGDGNLQYYLYNWRCPGTDSEKVGLVLQ
480 490
>>XP_005252699 (OMIM: 603801) PREDICTED: glycylpeptide N (495 aa)
initn: 2538 init1: 2352 opt: 2419 Z-score: 2311.4 bits: 437.2 E(85289): 5.2e-122
Smith-Waterman score: 2484; 72.9% identity (88.4% similar) in 502 aa overlap (1-490:1-492)
10 20 30 40 50
pF1KB5 MADESETAVKPPAPPLPQMMEGNGNGHEHCS-DCENEEDNSYNRGGLSPANDTGAKKKKK
::..::.:.. . : . .. :. : .:::.. . .: ::.. :::::::
XP_005 MAEDSESAASQQSLEL--------DDQDTCGIDGDNEEETEHAKG--SPGGYLGAKKKKK
10 20 30 40 50
60 70 80 90 100
pF1KB5 KQKKKKEK----GSETDSAQD-------QPVKMNSLPAERIQEIQKAIELFSVGQGPAKT
:::.:::: :...:::.: :: : :.: ...:.::.:.::.:. ::::..
XP_005 KQKRKKEKPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARN
60 70 80 90 100 110
110 120 130 140 150 160
pF1KB5 MEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGV
..::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.: :
XP_005 IDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEV
120 130 140 150 160 170
170 180 190 200 210 220
pF1KB5 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISA
::::::::::::::::::::::::::::::::::::::: :::::::: :..::::::::
XP_005 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISA
180 190 200 210 220 230
230 240 250 260 270 280
pF1KB5 IPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLP
:::::.:::. ::::::::::::::::::::::::::::::::.::::::::::::::::
XP_005 IPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLP
240 250 260 270 280 290
290 300 310 320 330 340
pF1KB5 KPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPV
::..::::::::::::::.::::::::::::.::::::::::.. ::.:::::: :::
XP_005 KPIATCRYWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKS
300 310 320 330 340 350
350 360 370 380 390 400
pF1KB5 VHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIM
:..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::::.:
XP_005 VRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVM
360 370 380 390 400 410
410 420 430 440 450 460
pF1KB5 NHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFG
.::.::::::::::::.::.:::::::::::.::: ::::::::::::::::::::::::
XP_005 HHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFG
420 430 440 450 460 470
470 480 490
pF1KB5 IGDGNLQYYLYNWKCPSMGAEKVGLVLQ
:::::::::::::.::. .::
XP_005 IGDGNLQYYLYNWRCPGTDSEKKVC
480 490
>>XP_016872436 (OMIM: 603801) PREDICTED: glycylpeptide N (502 aa)
initn: 2538 init1: 2352 opt: 2419 Z-score: 2311.3 bits: 437.2 E(85289): 5.3e-122
Smith-Waterman score: 2484; 72.9% identity (88.4% similar) in 502 aa overlap (1-490:1-492)
10 20 30 40 50
pF1KB5 MADESETAVKPPAPPLPQMMEGNGNGHEHCS-DCENEEDNSYNRGGLSPANDTGAKKKKK
::..::.:.. . : . .. :. : .:::.. . .: ::.. :::::::
XP_016 MAEDSESAASQQSLEL--------DDQDTCGIDGDNEEETEHAKG--SPGGYLGAKKKKK
10 20 30 40 50
60 70 80 90 100
pF1KB5 KQKKKKEK----GSETDSAQD-------QPVKMNSLPAERIQEIQKAIELFSVGQGPAKT
:::.:::: :...:::.: :: : :.: ...:.::.:.::.:. ::::..
XP_016 KQKRKKEKPNSGGTKSDSASDSQEIKIQQPSKNPSVPMQKLQDIQRAMELLSACQGPARN
60 70 80 90 100 110
110 120 130 140 150 160
pF1KB5 MEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGV
..::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.: :
XP_016 IDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEV
120 130 140 150 160 170
170 180 190 200 210 220
pF1KB5 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISA
::::::::::::::::::::::::::::::::::::::: :::::::: :..::::::::
XP_016 LKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISA
180 190 200 210 220 230
230 240 250 260 270 280
pF1KB5 IPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLP
:::::.:::. ::::::::::::::::::::::::::::::::.::::::::::::::::
XP_016 IPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLP
240 250 260 270 280 290
290 300 310 320 330 340
pF1KB5 KPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPV
::..::::::::::::::.::::::::::::.::::::::::.. ::.:::::: :::
XP_016 KPIATCRYWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKS
300 310 320 330 340 350
350 360 370 380 390 400
pF1KB5 VHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIM
:..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::::.:
XP_016 VRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVM
360 370 380 390 400 410
410 420 430 440 450 460
pF1KB5 NHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFG
.::.::::::::::::.::.:::::::::::.::: ::::::::::::::::::::::::
XP_016 HHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFG
420 430 440 450 460 470
470 480 490
pF1KB5 IGDGNLQYYLYNWKCPSMGAEKVGLVLQ
:::::::::::::.::. .::
XP_016 IGDGNLQYYLYNWRCPGTDSEKALYQPLKKSI
480 490 500
>>NP_001295224 (OMIM: 603801) glycylpeptide N-tetradecan (485 aa)
initn: 2370 init1: 2370 opt: 2373 Z-score: 2267.7 bits: 429.1 E(85289): 1.4e-119
Smith-Waterman score: 2373; 80.1% identity (94.1% similar) in 422 aa overlap (75-496:65-485)
50 60 70 80 90 100
pF1KB5 GLSPANDTGAKKKKKKQKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQG
..:: . :.: ...:.::.:.::.:. ::
NP_001 EAPSQTRHLIPRRLKFSSLRNTTPSGSRFQREQPWN-PSVPMQKLQDIQRAMELLSACQG
40 50 60 70 80 90
110 120 130 140 150 160
pF1KB5 PAKTMEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLG
::....::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.
NP_001 PARNIDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLS
100 110 120 130 140 150
170 180 190 200 210 220
pF1KB5 DRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVG
: :::::::::::::::::::::::::::::::::::::::: :::::::: :..::::
NP_001 DAEVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVG
160 170 180 190 200 210
230 240 250 260 270 280
pF1KB5 FISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAG
:::::::::.:::. ::::::::::::::::::::::::::::::::.::::::::::::
NP_001 FISAIPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAG
220 230 240 250 260 270
290 300 310 320 330 340
pF1KB5 VVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETK
::::::..::::::::::::::.::::::::::::.::::::::::.. ::.:::::: :
NP_001 VVLPKPIATCRYWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPK
280 290 300 310 320 330
350 360 370 380 390 400
pF1KB5 DIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLP
:: :..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::
NP_001 DIKSVRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLP
340 350 360 370 380 390
410 420 430 440 450 460
pF1KB5 STIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEK
::.:.::.::::::::::::.::.:::::::::::.::: ::::::::::::::::::::
NP_001 STVMHHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEK
400 410 420 430 440 450
470 480 490
pF1KB5 LKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ
:::::::::::::::::.::. .::::::::
NP_001 LKFGIGDGNLQYYLYNWRCPGTDSEKVGLVLQ
460 470 480
>>XP_016872442 (OMIM: 603801) PREDICTED: glycylpeptide N (411 aa)
initn: 2355 init1: 2355 opt: 2355 Z-score: 2251.6 bits: 425.8 E(85289): 1.1e-118
Smith-Waterman score: 2355; 81.5% identity (94.9% similar) in 410 aa overlap (87-496:2-411)
60 70 80 90 100 110
pF1KB5 KKKKQKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQGPAKTMEEASKRS
...:.::.:.::.:. ::::....::.:.
XP_016 MQKLQDIQRAMELLSACQGPARNIDEAAKHR
10 20 30
120 130 140 150 160 170
pF1KB5 YQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLL
:::::::::::: ::...:: .::::::.:::::.::::: ::.:::.: :::::::::
XP_016 YQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLL
40 50 60 70 80 90
180 190 200 210 220 230
pF1KB5 NENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIY
::::::::::::::::::::::::::::::: :::::::: :..:::::::::::::.::
XP_016 NENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIY
100 110 120 130 140 150
240 250 260 270 280 290
pF1KB5 DTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRY
:. ::::::::::::::::::::::::::::::::.::::::::::::::::::..::::
XP_016 DSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRY
160 170 180 190 200 210
300 310 320 330 340 350
pF1KB5 WHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRY
::::::::::.::::::::::::.::::::::::.. ::.:::::: ::: :..:.. :
XP_016 WHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTY
220 230 240 250 260 270
360 370 380 390 400 410
pF1KB5 LKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSL
::::::.:::..::: ::: :.:.::::::::. ::..::::::::::::.:.::.::::
XP_016 LKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSL
280 290 300 310 320 330
420 430 440 450 460 470
pF1KB5 KAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQY
::::::::.::.:::::::::::.::: ::::::::::::::::::::::::::::::::
XP_016 KAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQY
340 350 360 370 380 390
480 490
pF1KB5 YLYNWKCPSMGAEKVGLVLQ
:::::.::. .::::::::
XP_016 YLYNWRCPGTDSEKVGLVLQ
400 410
>>XP_016872438 (OMIM: 603801) PREDICTED: glycylpeptide N (482 aa)
initn: 2335 init1: 2335 opt: 2338 Z-score: 2234.4 bits: 422.9 E(85289): 1e-117
Smith-Waterman score: 2338; 79.8% identity (94.0% similar) in 416 aa overlap (75-490:65-479)
50 60 70 80 90 100
pF1KB5 GLSPANDTGAKKKKKKQKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQG
..:: . :.: ...:.::.:.::.:. ::
XP_016 EAPSQTRHLIPRRLKFSSLRNTTPSGSRFQREQPWN-PSVPMQKLQDIQRAMELLSACQG
40 50 60 70 80 90
110 120 130 140 150 160
pF1KB5 PAKTMEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLG
::....::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.
XP_016 PARNIDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLS
100 110 120 130 140 150
170 180 190 200 210 220
pF1KB5 DRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVG
: :::::::::::::::::::::::::::::::::::::::: :::::::: :..::::
XP_016 DAEVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVG
160 170 180 190 200 210
230 240 250 260 270 280
pF1KB5 FISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAG
:::::::::.:::. ::::::::::::::::::::::::::::::::.::::::::::::
XP_016 FISAIPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAG
220 230 240 250 260 270
290 300 310 320 330 340
pF1KB5 VVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETK
::::::..::::::::::::::.::::::::::::.::::::::::.. ::.:::::: :
XP_016 VVLPKPIATCRYWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPK
280 290 300 310 320 330
350 360 370 380 390 400
pF1KB5 DIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLP
:: :..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::
XP_016 DIKSVRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLP
340 350 360 370 380 390
410 420 430 440 450 460
pF1KB5 STIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEK
::.:.::.::::::::::::.::.:::::::::::.::: ::::::::::::::::::::
XP_016 STVMHHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEK
400 410 420 430 440 450
470 480 490
pF1KB5 LKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ
:::::::::::::::::.::. .::
XP_016 LKFGIGDGNLQYYLYNWRCPGTDSEKKVC
460 470 480
>>XP_016872437 (OMIM: 603801) PREDICTED: glycylpeptide N (489 aa)
initn: 2335 init1: 2335 opt: 2338 Z-score: 2234.3 bits: 422.9 E(85289): 1e-117
Smith-Waterman score: 2338; 79.8% identity (94.0% similar) in 416 aa overlap (75-490:65-479)
50 60 70 80 90 100
pF1KB5 GLSPANDTGAKKKKKKQKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQG
..:: . :.: ...:.::.:.::.:. ::
XP_016 EAPSQTRHLIPRRLKFSSLRNTTPSGSRFQREQPWN-PSVPMQKLQDIQRAMELLSACQG
40 50 60 70 80 90
110 120 130 140 150 160
pF1KB5 PAKTMEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLG
::....::.:. :::::::::::: ::...:: .::::::.:::::.::::: ::.:::.
XP_016 PARNIDEAAKHRYQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLS
100 110 120 130 140 150
170 180 190 200 210 220
pF1KB5 DRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVG
: :::::::::::::::::::::::::::::::::::::::: :::::::: :..::::
XP_016 DAEVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVG
160 170 180 190 200 210
230 240 250 260 270 280
pF1KB5 FISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAG
:::::::::.:::. ::::::::::::::::::::::::::::::::.::::::::::::
XP_016 FISAIPANIRIYDSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAG
220 230 240 250 260 270
290 300 310 320 330 340
pF1KB5 VVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETK
::::::..::::::::::::::.::::::::::::.::::::::::.. ::.:::::: :
XP_016 VVLPKPIATCRYWHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPK
280 290 300 310 320 330
350 360 370 380 390 400
pF1KB5 DIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLP
:: :..:.. :::::::.:::..::: ::: :.:.::::::::. ::..::::::::::
XP_016 DIKSVRELINTYLKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLP
340 350 360 370 380 390
410 420 430 440 450 460
pF1KB5 STIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEK
::.:.::.::::::::::::.::.:::::::::::.::: ::::::::::::::::::::
XP_016 STVMHHPAHKSLKAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEK
400 410 420 430 440 450
470 480 490
pF1KB5 LKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ
:::::::::::::::::.::. .::
XP_016 LKFGIGDGNLQYYLYNWRCPGTDSEKALYQPLKKSI
460 470 480
>>XP_016872441 (OMIM: 603801) PREDICTED: glycylpeptide N (415 aa)
initn: 2320 init1: 2320 opt: 2320 Z-score: 2218.2 bits: 419.7 E(85289): 8.1e-117
Smith-Waterman score: 2320; 81.2% identity (94.8% similar) in 404 aa overlap (87-490:2-405)
60 70 80 90 100 110
pF1KB5 KKKKQKKKKEKGSETDSAQDQPVKMNSLPAERIQEIQKAIELFSVGQGPAKTMEEASKRS
...:.::.:.::.:. ::::....::.:.
XP_016 MQKLQDIQRAMELLSACQGPARNIDEAAKHR
10 20 30
120 130 140 150 160 170
pF1KB5 YQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLL
:::::::::::: ::...:: .::::::.:::::.::::: ::.:::.: :::::::::
XP_016 YQFWDTQPVPKLDEVITSHGAIEPDKDNVRQEPYSLPQGFMWDTLDLSDAEVLKELYTLL
40 50 60 70 80 90
180 190 200 210 220 230
pF1KB5 NENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIY
::::::::::::::::::::::::::::::: :::::::: :..:::::::::::::.::
XP_016 NENYVEDDDNMFRFDYSPEFLLWALRPPGWLLQWHCGVRVSSNKKLVGFISAIPANIRIY
100 110 120 130 140 150
240 250 260 270 280 290
pF1KB5 DTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRY
:. ::::::::::::::::::::::::::::::::.::::::::::::::::::..::::
XP_016 DSVKKMVEINFLCVHKKLRSKRVAPVLIREITRRVNLEGIFQAVYTAGVVLPKPIATCRY
160 170 180 190 200 210
300 310 320 330 340 350
pF1KB5 WHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRY
::::::::::.::::::::::::.::::::::::.. ::.:::::: ::: :..:.. :
XP_016 WHRSLNPRKLVEVKFSHLSRNMTLQRTMKLYRLPDVTKTSGLRPMEPKDIKSVRELINTY
220 230 240 250 260 270
360 370 380 390 400 410
pF1KB5 LKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSL
::::::.:::..::: ::: :.:.::::::::. ::..::::::::::::.:.::.::::
XP_016 LKQFHLAPVMDEEEVAHWFLPREHIIDTFVVESPNGKLTDFLSFYTLPSTVMHHPAHKSL
280 290 300 310 320 330
420 430 440 450 460 470
pF1KB5 KAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQY
::::::::.::.:::::::::::.::: ::::::::::::::::::::::::::::::::
XP_016 KAAYSFYNIHTETPLLDLMSDALILAKSKGFDVFNALDLMENKTFLEKLKFGIGDGNLQY
340 350 360 370 380 390
480 490
pF1KB5 YLYNWKCPSMGAEKVGLVLQ
:::::.::. .::
XP_016 YLYNWRCPGTDSEKALYQPLKKSI
400 410
496 residues in 1 query sequences
60827320 residues in 85289 library sequences
Tcomplib [36.3.4 Apr, 2011] (8 proc)
start: Sat Nov 5 10:35:44 2016 done: Sat Nov 5 10:35:45 2016
Total Scan time: 7.310 Total Display time: 0.060
Function used was FASTA [36.3.4 Apr, 2011]